FSD Pharma Announces First Patient Randomized in Phase 2 Trial of FSD201 for the Treatment of Hospitalized Patients with COVID-19
Dec 15, 2020
FSD Pharma Announces Third Quarter 2020 Financial Results and Provides Corporate Update
Nov 12, 2020
FSD Pharma Announces Settlement of Class Action Proceeding
Oct 29, 2020